Home＞BUSINESS
Pharma Leaders Urge Govt to Lend Ear to Industry Opinions for Pricing Revamp(Jan.10.2017)
Pharmaceutical industry bigwigs at a New Year’s reception on January 6 called on the government to have them join discussions on the planned revamp of Japan’s drug pricing system, including the proposed introduction of annual price revisions, and reflect their views to the reform...
(LOG IN FOR FULL STORY)
-
- MHLW Lifts Contraindications for Combined Statin-Fibrate Use in Renal-Impaired Patients Oct.17
- ADR Victim Relief Claims Fall below 1,500 in FY2017: MHLW Oct.17
- As Abe Vows to Deliver on Tax Hike Plan, 3 Pharma Groups to Push for October 2019 Price Revision Oct.16
- MEXT Kicks Off “Open Innovation Organization” Initiative, 3 Universities to Push Drug Discovery Oct.15
-
Nobel Laurate Honjo Prods Minister on Industry Consolidation
Oct.12
- JAK Inhibitor Battle for Atopic Dermatitis Intensifying, 1st Japan Filing Might Be Near(Oct.17)
- MHLW Lifts Contraindications for Combined Statin-Fibrate Use in Renal-Impaired Patients(Oct.17)
- Eisai Seals Latin America Pact for Belviq(Oct.17)
- Teva Takeda Launches Voluntary Recall for Taxotere Generics(Oct.17)
- ADR Victim Relief Claims Fall below 1,500 in FY2017: MHLW(Oct.17)
